| Metric | Q4 2025 | Q3 2025 | Q4 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $241M | — | — | — | — |
| Op. Income | $6M | — | — | — | — |
| Gross Margin | 96.3% | — | — | — | — |
| Net Margin | 3.0% | — | — | — | — |
| EPS (Diluted) | $0.17 | — | — | — | — |
| Free Cash Flow | $11M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $241M |
| Cost of Revenue | $9M |
| GROSS PROFIT | $232M |
| R&D Expenses | $16M |
| Selling & Marketing | $120M |
| General & Administrative | $62M |
| SG&A Expenses | $182M |
| Other Expenses | $28M |
| Operating Expenses | $226M |
| Cost & Expenses | $235M |
| OPERATING INCOME | $6M |
| Interest Income | $0 |
| Interest Expense | $5M |
| Other Income/Expenses | -$1M |
| INCOME BEFORE TAX | $4M |
| Income Tax Expense | $3M |
| Net Income from Continuing Ops | $7M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $7M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $7M |
| D&A | $15M |
| EBIT | $10M |
| EBITDA | $25M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $241M |
| Cost of Revenue | $9M |
| GROSS PROFIT | $232M |
| R&D Expenses | $16M |
| Selling & Marketing | $120M |
| General & Administrative | $62M |
| SG&A Expenses | $182M |
| Other Expenses | $28M |
| Operating Expenses | $226M |
| Cost & Expenses | $235M |
| OPERATING INCOME | $6M |
| Interest Income | $0 |
| Interest Expense | $5M |
| Other Income/Expenses | -$1M |
| INCOME BEFORE TAX | $4M |
| Income Tax Expense | $3M |
| Net Income from Continuing Ops | $7M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $7M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $7M |
| D&A | $15M |
| EBIT | $10M |
| EBITDA | $25M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $7M |
| Depreciation & Amortization | $15M |
| Stock-Based Compensation | $6M |
| Deferred Income Tax | -$4M |
| Other Non-Cash Items | $76M |
| Change in Working Capital | -$70M |
| OPERATING CASH FLOW | $30M |
| Capital Expenditure | -$19M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$75.0K |
| NET CASH FROM INVESTING | -$19M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | -$46M |
| Common Dividends Paid | $0 |
| Other Financing Activities | $110M |
| NET CASH FROM FINANCING | $110M |
| FREE CASH FLOW | $11M |
| Net Change in Cash | -$37M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $304M |
| Short-Term Investments | $0 |
| Net Receivables | $33M |
| Inventory | $0 |
| Other Current Assets | $30M |
| TOTAL CURRENT ASSETS | $366M |
| PP&E (Net) | $0 |
| Goodwill | $890M |
| Intangible Assets | $167M |
| Long-Term Investments | $0 |
| Tax Assets | $126M |
| Other Non-Current Assets | $131M |
| TOTAL NON-CURRENT ASSETS | $1.3B |
| TOTAL ASSETS | $1.7B |
| Account Payables | $34M |
| Short-Term Debt | $0 |
| Deferred Revenue | $22M |
| Other Current Liabilities | $166M |
| TOTAL CURRENT LIABILITIES | $222M |
| Long-Term Debt | $0 |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $1M |
| Other Non-Current Liabilities | $529M |
| TOTAL NON-CURRENT LIABILITIES | $531M |
| TOTAL LIABILITIES | $753M |
| Common Stock | $538.0K |
| Additional Paid-In Capital | $0 |
| Retained Earnings | -$151M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $6M |
| Other Equity | $1.1B |
| TOTAL STOCKHOLDERS' EQUITY | $927M |
| Minority Interest | $0 |
| TOTAL EQUITY | $927M |
| TOTAL LIABILITIES & EQUITY | $1.7B |
| Total Debt | $0 |
| Net Debt | -$304M |
